BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6214877)

  • 1. Natural killer cells and their possible relevance to transplantation biology.
    Herberman RB
    Transplantation; 1982 Jul; 34(1):1-7. PubMed ID: 6214877
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo generation, enhancement and recruitment of host cellular immune responses against tumor: influence of MHC antigen expression on clones of tumor cell variants.
    Fernández-Cruz E; Pérez M; Zabay JM; Garrido F
    Prog Clin Biol Res; 1987; 244():115-25. PubMed ID: 2958867
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural killer (NK) cells and their possible roles in resistance against disease.
    Herberman RB
    Clin Immunol Rev; 1981; 1(1):1-65. PubMed ID: 6219848
    [No Abstract]   [Full Text] [Related]  

  • 4. A human large granular lymphocyte clone with natural killer-like activity and T cell-like surface markers.
    Sheehy MJ; Quintieri FB; Leung DY; Geha RS; Dubey DP; Limmer CE; Yunis EJ
    J Immunol; 1983 Feb; 130(2):524-6. PubMed ID: 6600239
    [No Abstract]   [Full Text] [Related]  

  • 5. T-T cell interactions in cell-mediated immune responses to major histocompatibility complex antigens.
    Rich RR; Rich SS
    Crit Rev Immunol; 1983; 4(2):129-68. PubMed ID: 6221885
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia.
    Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):377-9. PubMed ID: 238679
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation.
    Keever CA; Welte K; Sullivan M; O'Reilly RJ
    Prog Clin Biol Res; 1987; 244():423-32. PubMed ID: 3310004
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens.
    Muto M; Sado T; Aizawa S; Kamisaku H; Kubo E
    J Immunol; 1981 Dec; 127(6):2421-5. PubMed ID: 6457876
    [No Abstract]   [Full Text] [Related]  

  • 9. Workshop summary on genetic determinants of cell-mediated immune reactions in the mouse.
    Festenstein H; Démant P
    Transplant Proc; 1973 Dec; 5(4):1321-7. PubMed ID: 4149543
    [No Abstract]   [Full Text] [Related]  

  • 10. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells and tumor immunity: 1985.
    Herberman RB
    Year Immunol; 1986; 2():254-60. PubMed ID: 3033946
    [No Abstract]   [Full Text] [Related]  

  • 12. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular base immunologic recognition. I. Relationship and cooperative interaction between subpopulations of T- and B-lymphocytes during the process of primary immunologic recognition].
    Brondz BD
    Usp Sovrem Biol; 1977; 84(5):219-35. PubMed ID: 27026
    [No Abstract]   [Full Text] [Related]  

  • 14. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts.
    Miller SC
    Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the relationship between initiator and effector cells in the response to major tansplantation antigens.
    Howard JC
    Transplant Proc; 1973 Dec; 5(4):1451-6. PubMed ID: 4130057
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunomodulatory effects of interferons on human mononuclear cells with special reference to the expression of cell surface antigens.
    Hokland ME
    Acta Pathol Microbiol Immunol Scand Suppl; 1985; 286():1-35. PubMed ID: 2408439
    [No Abstract]   [Full Text] [Related]  

  • 19. [Types of cellular antitumor cytotoxicity].
    Lomakin MS; Maĭskiĭ IN
    Vopr Onkol; 1988; 34(12):1422-32. PubMed ID: 2975420
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction.
    Bruley-Rosset M; Miconnet I; Roger T; Seman M; Halle-Pannenko O
    Transplant Proc; 1993 Feb; 25(1 Pt 1):94-5. PubMed ID: 8438503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.